Clinical Trials Directory

Trials / Unknown

UnknownNCT05634655

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors.

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

DNA methylation is one of the important ways of protein post-translational modification.Pituitary adenoma (PA) is a benign neuroendocrine tumor that originates from adenohypophysial 45 cells, and accounts for 10%-20% of all primary intracranial tumors. However some PAs can present with high invasiveness and irregular growth, which tend to compresses the optic chiasm and third ventricle, encase the internal carotid artery, and affect hormone secretion from the pituitary gland and hypothalamus. In this study we focus on the mechanism of DNA methylation on the invasiveness of pituitary tumors.

Conditions

Interventions

TypeNameDescription
OTHERno interventions between two groupsno interventions between two groups

Timeline

Start date
2022-01-01
Primary completion
2022-12-31
Completion
2025-01-01
First posted
2022-12-02
Last updated
2022-12-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05634655. Inclusion in this directory is not an endorsement.

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors. (NCT05634655) · Clinical Trials Directory